| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971857 | The Journal of Heart and Lung Transplantation | 2009 | 6 Pages |
Abstract
Although rFVIIa administration seemed helpful in controlling life-threatening hemorrhage, patients requiring higher doses (30 to 70 μg/kg) had a dramatically higher incidence of serious thromboembolic events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian A. MD, Daniel J. MD, Qian PA-C, Alfred MD, Karim MD, Jamie MD, John MD, Paul M. MD, Denton A. MD, Igor D. MD, Oscar H. MD,